img

Global CAR T-cell Therapy Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-cell Therapy Drug Market Insights, Forecast to 2034

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
Market Analysis and InsightsGlobal CAR T-cell Therapy Drug Market
Global CAR T-cell Therapy Drug market is expected to reach to US$ 4087 million in 2024, with a positive growth of %, compared with US$ 2805.8 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CAR T-cell Therapy Drug industry is evaluated to reach US$ 19640 million in 2029. The CAGR will be 29.9% during 2024 to 2029.
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient's own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.
Report Covers
This report presents an overview of global CAR T-cell Therapy Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global CAR T-cell Therapy Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, CAR T-cell Therapy Drug introduction, etc. CAR T-cell Therapy Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of CAR T-cell Therapy Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-cell Therapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-cell Therapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-cell Therapy Drug Market Perspective (2018-2029)
2.2 Global CAR T-cell Therapy Drug Growth Trends by Region
2.2.1 CAR T-cell Therapy Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR T-cell Therapy Drug Historic Market Size by Region (2018-2024)
2.2.3 CAR T-cell Therapy Drug Forecasted Market Size by Region (2024-2029)
2.3 CAR T-cell Therapy Drug Market Dynamics
2.3.1 CAR T-cell Therapy Drug Industry Trends
2.3.2 CAR T-cell Therapy Drug Market Drivers
2.3.3 CAR T-cell Therapy Drug Market Challenges
2.3.4 CAR T-cell Therapy Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CAR T-cell Therapy Drug by Players
3.1.1 Global CAR T-cell Therapy Drug Revenue by Players (2018-2024)
3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Players (2018-2024)
3.2 Global CAR T-cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR T-cell Therapy Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global CAR T-cell Therapy Drug Market Concentration Ratio
3.4.1 Global CAR T-cell Therapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-cell Therapy Drug Revenue in 2022
3.5 Global Key Players of CAR T-cell Therapy Drug Head office and Area Served
3.6 Global Key Players of CAR T-cell Therapy Drug, Product and Application
3.7 Global Key Players of CAR T-cell Therapy Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-cell Therapy Drug Breakdown Data by Type
4.1 Global CAR T-cell Therapy Drug Historic Market Size by Type (2018-2024)
4.2 Global CAR T-cell Therapy Drug Forecasted Market Size by Type (2024-2029)
5 CAR T-cell Therapy Drug Breakdown Data by Application
5.1 Global CAR T-cell Therapy Drug Historic Market Size by Application (2018-2024)
5.2 Global CAR T-cell Therapy Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CAR T-cell Therapy Drug Market Size (2018-2029)
6.2 North America CAR T-cell Therapy Drug Market Size by Type
6.2.1 North America CAR T-cell Therapy Drug Market Size by Type (2018-2024)
6.2.2 North America CAR T-cell Therapy Drug Market Size by Type (2024-2029)
6.2.3 North America CAR T-cell Therapy Drug Market Share by Type (2018-2029)
6.3 North America CAR T-cell Therapy Drug Market Size by Application
6.3.1 North America CAR T-cell Therapy Drug Market Size by Application (2018-2024)
6.3.2 North America CAR T-cell Therapy Drug Market Size by Application (2024-2029)
6.3.3 North America CAR T-cell Therapy Drug Market Share by Application (2018-2029)
6.4 North America CAR T-cell Therapy Drug Market Size by Country
6.4.1 North America CAR T-cell Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CAR T-cell Therapy Drug Market Size by Country (2018-2024)
6.4.3 North America CAR T-cell Therapy Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CAR T-cell Therapy Drug Market Size (2018-2029)
7.2 Europe CAR T-cell Therapy Drug Market Size by Type
7.2.1 Europe CAR T-cell Therapy Drug Market Size by Type (2018-2024)
7.2.2 Europe CAR T-cell Therapy Drug Market Size by Type (2024-2029)
7.2.3 Europe CAR T-cell Therapy Drug Market Share by Type (2018-2029)
7.3 Europe CAR T-cell Therapy Drug Market Size by Application
7.3.1 Europe CAR T-cell Therapy Drug Market Size by Application (2018-2024)
7.3.2 Europe CAR T-cell Therapy Drug Market Size by Application (2024-2029)
7.3.3 Europe CAR T-cell Therapy Drug Market Share by Application (2018-2029)
7.4 Europe CAR T-cell Therapy Drug Market Size by Country
7.4.1 Europe CAR T-cell Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CAR T-cell Therapy Drug Market Size by Country (2018-2024)
7.4.3 Europe CAR T-cell Therapy Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CAR T-cell Therapy Drug Market Size (2018-2029)
8.2 China CAR T-cell Therapy Drug Market Size by Type
8.2.1 China CAR T-cell Therapy Drug Market Size by Type (2018-2024)
8.2.2 China CAR T-cell Therapy Drug Market Size by Type (2024-2029)
8.2.3 China CAR T-cell Therapy Drug Market Share by Type (2018-2029)
8.3 China CAR T-cell Therapy Drug Market Size by Application
8.3.1 China CAR T-cell Therapy Drug Market Size by Application (2018-2024)
8.3.2 China CAR T-cell Therapy Drug Market Size by Application (2024-2029)
8.3.3 China CAR T-cell Therapy Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia CAR T-cell Therapy Drug Market Size (2018-2029)
9.2 Asia CAR T-cell Therapy Drug Market Size by Type
9.2.1 Asia CAR T-cell Therapy Drug Market Size by Type (2018-2024)
9.2.2 Asia CAR T-cell Therapy Drug Market Size by Type (2024-2029)
9.2.3 Asia CAR T-cell Therapy Drug Market Share by Type (2018-2029)
9.3 Asia CAR T-cell Therapy Drug Market Size by Application
9.3.1 Asia CAR T-cell Therapy Drug Market Size by Application (2018-2024)
9.3.2 Asia CAR T-cell Therapy Drug Market Size by Application (2024-2029)
9.3.3 Asia CAR T-cell Therapy Drug Market Share by Application (2018-2029)
9.4 Asia CAR T-cell Therapy Drug Market Size by Region
9.4.1 Asia CAR T-cell Therapy Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CAR T-cell Therapy Drug Market Size by Region (2018-2024)
9.4.3 Asia CAR T-cell Therapy Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-cell Therapy Drug Introduction
11.1.4 Novartis Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-cell Therapy Drug Introduction
11.2.4 Gilead Sciences Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-cell Therapy Drug Introduction
11.4.4 J & J Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.4.5 J & J Recent Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-cell Therapy Drug Introduction
11.5.4 JW Therapeutics Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.5.5 JW Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-cell Therapy Drug Introduction
11.6.4 FOSUNKite Revenue in CAR T-cell Therapy Drug Business (2018-2024)
11.6.5 FOSUNKite Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR T-cell Therapy Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global CAR T-cell Therapy Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CAR T-cell Therapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR T-cell Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CAR T-cell Therapy Drug Market Share by Region (2018-2024)
Table 8. Global CAR T-cell Therapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR T-cell Therapy Drug Market Share by Region (2024-2029)
Table 10. CAR T-cell Therapy Drug Market Trends
Table 11. CAR T-cell Therapy Drug Market Drivers
Table 12. CAR T-cell Therapy Drug Market Challenges
Table 13. CAR T-cell Therapy Drug Market Restraints
Table 14. Global CAR T-cell Therapy Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CAR T-cell Therapy Drug Revenue Share by Players (2018-2024)
Table 16. Global Top CAR T-cell Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-cell Therapy Drug as of 2022)
Table 17. Global CAR T-cell Therapy Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by CAR T-cell Therapy Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of CAR T-cell Therapy Drug, Headquarters and Area Served
Table 20. Global Key Players of CAR T-cell Therapy Drug, Product and Application
Table 21. Global Key Players of CAR T-cell Therapy Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CAR T-cell Therapy Drug Revenue Market Share by Type (2018-2024)
Table 25. Global CAR T-cell Therapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR T-cell Therapy Drug Revenue Market Share by Type (2024-2029)
Table 27. Global CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CAR T-cell Therapy Drug Revenue Share by Application (2018-2024)
Table 29. Global CAR T-cell Therapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR T-cell Therapy Drug Revenue Share by Application (2024-2029)
Table 31. North America CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CAR T-cell Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CAR T-cell Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CAR T-cell Therapy Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CAR T-cell Therapy Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia CAR T-cell Therapy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis CAR T-cell Therapy Drug Product
Table 66. Novartis Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences CAR T-cell Therapy Drug Product
Table 71. Gilead Sciences Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb CAR T-cell Therapy Drug Product
Table 76. Bristol-Myers Squibb Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Developments
Table 78. J & J Company Details
Table 79. J & J Business Overview
Table 80. J & J CAR T-cell Therapy Drug Product
Table 81. J & J Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 82. J & J Recent Developments
Table 83. JW Therapeutics Company Details
Table 84. JW Therapeutics Business Overview
Table 85. JW Therapeutics CAR T-cell Therapy Drug Product
Table 86. JW Therapeutics Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 87. JW Therapeutics Recent Developments
Table 88. FOSUNKite Company Details
Table 89. FOSUNKite Business Overview
Table 90. FOSUNKite CAR T-cell Therapy Drug Product
Table 91. FOSUNKite Revenue in CAR T-cell Therapy Drug Business (2018-2024) & (US$ Million)
Table 92. FOSUNKite Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-cell Therapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CAR T-cell Therapy Drug Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global CAR T-cell Therapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CAR T-cell Therapy Drug Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. CAR T-cell Therapy Drug Report Years Considered
Figure 10. Global CAR T-cell Therapy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global CAR T-cell Therapy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CAR T-cell Therapy Drug Market Share by Region: 2022 VS 2029
Figure 13. Global CAR T-cell Therapy Drug Market Share by Players in 2022
Figure 14. Global Top CAR T-cell Therapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-cell Therapy Drug as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-cell Therapy Drug Revenue in 2022
Figure 16. North America CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America CAR T-cell Therapy Drug Market Share by Type (2018-2029)
Figure 18. North America CAR T-cell Therapy Drug Market Share by Application (2018-2029)
Figure 19. North America CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 20. United States CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe CAR T-cell Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe CAR T-cell Therapy Drug Market Share by Type (2018-2029)
Figure 24. Europe CAR T-cell Therapy Drug Market Share by Application (2018-2029)
Figure 25. Europe CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 26. Germany CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China CAR T-cell Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China CAR T-cell Therapy Drug Market Share by Type (2018-2029)
Figure 34. China CAR T-cell Therapy Drug Market Share by Application (2018-2029)
Figure 35. Asia CAR T-cell Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia CAR T-cell Therapy Drug Market Share by Type (2018-2029)
Figure 37. Asia CAR T-cell Therapy Drug Market Share by Application (2018-2029)
Figure 38. Asia CAR T-cell Therapy Drug Market Share by Region (2018-2029)
Figure 39. Japan CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America CAR T-cell Therapy Drug Market Share by Country (2018-2029)
Figure 49. Brazil CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries CAR T-cell Therapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Novartis Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 56. Gilead Sciences Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 58. J & J Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 59. JW Therapeutics Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 60. FOSUNKite Revenue Growth Rate in CAR T-cell Therapy Drug Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries